about
Walking towards personalized medicine in pulmonary rehabilitation: Comorbidities and COPD.Building consensus for provision of breathlessness rehabilitation for patients with chronic obstructive pulmonary disease and chronic heart failure.Optimising prescription and titration of oxygen for adult inpatients using novel silicone wristbands: results of a pilot project at three centres.Protocol for a feasibility study to inform the development of a multicentre randomised controlled trial of asthma-tailored pulmonary rehabilitation versus usual care for individuals with severe asthma.Developing the model of pulmonary rehabilitation for chronic heart failure.Systematic review of supervised exercise programs after pulmonary rehabilitation in individuals with COPD.Defining hyperinflation as 'dynamic': moving toward the slope.Measurement properties of the incremental shuttle walk test. a systematic review.Cardiac management of ventilator-assisted individuals with Duchenne muscular dystrophy.The systemic nature of chronic lung disease.Is quadriceps endurance reduced in COPD?: a systematic review.Comprehensive respiratory assessment in advanced COPD: a 'campus to clinic' translational framework.The effects of exercise modality and intensity on energy expenditure and cardiorespiratory response in adults with obesity and treated obstructive sleep apnoea.One-Legged Cycle Training for Chronic Obstructive Pulmonary Disease. A Pragmatic Study of Implementation to Pulmonary Rehabilitation.Repeatability of usual and fast walking speeds in patients with chronic obstructive pulmonary disease.Has my patient responded? Interpreting clinical measurements such as the 6-minute-walk test.Pulmonary Rehabilitation: The Lead Singer of COPD Therapy but Not a "One-Man Band".Gait Speed: Validity of Measurement in Patients With Severe Chronic Lung Disease, Including Prognostic and Practical Implications.Influence of muscle mass in the assessment of lower limb strength in COPD: validation of the prediction equation.Obesity and metabolic syndrome in COPD: is exercise the answer?Do field walking tests produce similar cardiopulmonary demands to an incremental treadmill test in obese individuals with treated OSA?Does body mass index influence the outcomes of a Waking-based pulmonary rehabilitation programme in COPD?A counterweight is not necessary to implement simple, natural and comfortable single-leg cycle training.Breathing helium-hyperoxia and tolerance of partitioned exercise in patients with COPD.The effect of pulmonary rehabilitation on critical walk speed in patients with COPD: a comparison with self-paced walks.Properties of self-paced walking in chronic respiratory disease: a patient goal-oriented assessment.Long-term oxygen therapy: still not preventing the blues.Moving more: our heart cares but do our lungs?The Development of a Self-Reported Version of the Chronic Heart QuestionnaireGeneric, symptom based, exercise rehabilitation; integrating patients with COPD and heart failurePulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea gradeMinimum clinically important improvement for the incremental shuttle walking testCardiorespiratory Responses between One-legged and Two-legged Cycling in Patients with Idiopathic Pulmonary FibrosisA comparison of daily physical activity profiles between adults with severe asthma and healthy controlsProtocol for a feasibility trial to inform the development of a breathlessness rehabilitation programme for chronic obstructive pulmonary disease and chronic heart failure (the COHERE trial)Rehabilitation in lung diseases: 'Education' component of pulmonary rehabilitationMinimum important difference of the incremental shuttle walk test distance in patients with COPDUnderstanding the measurement properties of the incremental shuttle walk test in patients with severe asthma
P50
Q30248639-60ADB9E9-94AD-4AE9-A493-56B6FA6AD987Q34521930-7381F7E3-C12A-4EE8-9C61-0679DC7B2939Q36092152-BDB9D654-90C6-4DBC-BDD2-8A9C2914784CQ36732867-EAE9F1C8-42D8-4713-910B-05A7B20A7ECFQ37957593-97B280CC-7C68-4A7E-B535-9B2FB23E8C1AQ38083547-CE96176A-964E-4FFD-9974-7FD4B18D78C8Q38088084-4648E805-6555-4DD2-830B-58D755F7B913Q38175270-517FB3A8-C394-49B0-B48E-8A4DD6965E15Q38204281-CBCB1FE0-E7A3-41C1-9DD1-EAA726989709Q38215816-360A592D-E381-42F0-ACDC-0784E0587807Q38262224-A4486C06-2ED3-4E1B-B629-A39096F02B13Q38474377-B90ACB72-64B0-47BE-BCC7-2E0DE4CF2C52Q40716125-805DEB05-3668-4374-A466-A99A4365F9F7Q41042273-A63A0D78-5A5D-4C5A-81C1-4191E8F34939Q45091490-4AA2FBA3-C536-41CE-B6DA-31E3B7078D22Q45940710-10D9A86B-C9A1-4D35-A605-7AEE19AD0946Q47685415-ECFE5C94-EF36-459F-86D9-07B79C0008A1Q47685800-867D0193-E4C7-47FE-96E3-A90D20AD454CQ47702584-067100CE-3CD8-43AB-9E2E-8619AEB99BDFQ47850975-26B0BF08-D0A7-44AB-8462-A35F2812A622Q48123092-981B0EDB-B281-4613-94B5-5C2478B710AEQ50500889-D2562B4E-12B3-4A39-AA08-3F79310F2BA2Q53270186-FEB04365-383C-4D16-BD24-A780796AE656Q53307373-C9C0005E-2580-4984-98B0-7133C8F2326EQ53414384-76462272-6301-494F-A5C7-2D509DA7F00AQ53434522-915A15E1-C977-4779-B9C0-4708B599C394Q53440120-A5CBDF64-0AEE-413D-91A9-203BA95171C2Q54234711-916F5ACC-9E82-406D-8B1A-9281CAA05E1AQ60216639-213C82B2-7EE6-416C-9787-8590EE389729Q60216646-88598F00-7602-4B20-9B85-41E9E9740555Q60216650-4F15FF16-5B69-42D4-912C-0B2E2DE4EB06Q60216656-0BC103B8-03C8-49A6-95B9-CC867F548F58Q90589372-5DE5A0D2-1EC4-4373-AED7-B6EC0845D20AQ91707493-D5A61FEC-5A40-42EA-97BC-D957A386FE79Q91966479-C3236278-8261-4C76-AEFF-ED0020A41965Q92104663-39E5C5DA-08CB-47B0-AD22-B7731A37A477Q92417904-36013A5D-34D4-41C2-97B2-1C2D13154E2BQ92468994-0F58135E-AEE0-4101-8BFB-D58DC5F42D97
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rachael A Evans
@ast
Rachael A Evans
@en
Rachael A Evans
@es
Rachael A Evans
@nl
Rachael A Evans
@sl
type
label
Rachael A Evans
@ast
Rachael A Evans
@en
Rachael A Evans
@es
Rachael A Evans
@nl
Rachael A Evans
@sl
prefLabel
Rachael A Evans
@ast
Rachael A Evans
@en
Rachael A Evans
@es
Rachael A Evans
@nl
Rachael A Evans
@sl
P108
P106
P108
P21
P31
P496
0000-0002-1667-868X